Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Fox

Showing results (171-180 of 258) with videos related to

Pageof 26
Sort By:
The Journal of Pathology|March 1, 2016
VEGF-D promotes pulmonary oedema in hyperoxic acute lung injuryTeruhiko Sato, Sophie Paquet-Fifield, Nicole C Harris, et al.
The Journal of Pathology|January 19, 2017
MDM4 is a rational target for treating breast cancers with mutant p53Panimaya Jeffreena Miranda, Daniel Buckley, Dinesh Raghu, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
Breast Cancer Research and Treatment|January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cellsMara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.
Internal Medicine Journal|April 3, 2018
Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical settingBelinda Lee, Ben Tran, Arthur L Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinibJochen K Lennerz, Eunice L Kwak, Allison Ackerman, et al.
Journal of Personalized Medicine|November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the ClinicJohn P Parisot, Heather Thorne, Andrew Fellowes, et al.
Breast Cancer Research and Treatment|August 10, 2020
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory studyFrancesco Schettini, Navid Sobhani, Anna Ianza, et al.
Cell Death & Disease|September 8, 2022
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten lossJavier Octavio Mejía-Hernández, Simon P Keam, Reem Saleh, et al.
Histopathology|February 15, 2020
The 2019 World Health Organization classification of tumours of the breastPuay Hoon Tan, Ian Ellis, Kimberly Allison, et al.
Pageof 26

Showing results (171-180 of 258) with videos related to

Sort By:
Pageof 26
The Journal of Pathology|March 1, 2016
VEGF-D promotes pulmonary oedema in hyperoxic acute lung injuryTeruhiko Sato, Sophie Paquet-Fifield, Nicole C Harris, et al.
The Journal of Pathology|January 19, 2017
MDM4 is a rational target for treating breast cancers with mutant p53Panimaya Jeffreena Miranda, Daniel Buckley, Dinesh Raghu, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
Breast Cancer Research and Treatment|January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cellsMara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.
Internal Medicine Journal|April 3, 2018
Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical settingBelinda Lee, Ben Tran, Arthur L Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinibJochen K Lennerz, Eunice L Kwak, Allison Ackerman, et al.
Journal of Personalized Medicine|November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the ClinicJohn P Parisot, Heather Thorne, Andrew Fellowes, et al.
Breast Cancer Research and Treatment|August 10, 2020
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory studyFrancesco Schettini, Navid Sobhani, Anna Ianza, et al.
Cell Death & Disease|September 8, 2022
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten lossJavier Octavio Mejía-Hernández, Simon P Keam, Reem Saleh, et al.
Histopathology|February 15, 2020
The 2019 World Health Organization classification of tumours of the breastPuay Hoon Tan, Ian Ellis, Kimberly Allison, et al.
Pageof 26